Study | Reason for exclusion |
---|---|
M‐V KR 2001 | This is not a trial of the efficacy and safety of D9‐THC. Instead it presents data to support the view that D9‐THC does not have a negative impact on neuropsychological performance, when given as a single dose to 12 patients. |
M‐V KR 2003 | This study presents evidence that there were neither acute nor long term cognitive deficits in patients given 6 weeks treatment with D9‐THC. |